IL161320A0 - Quinoline derivatives, synthesis method, and medicines containing said derivatives - Google Patents

Quinoline derivatives, synthesis method, and medicines containing said derivatives

Info

Publication number
IL161320A0
IL161320A0 IL16132002A IL16132002A IL161320A0 IL 161320 A0 IL161320 A0 IL 161320A0 IL 16132002 A IL16132002 A IL 16132002A IL 16132002 A IL16132002 A IL 16132002A IL 161320 A0 IL161320 A0 IL 161320A0
Authority
IL
Israel
Prior art keywords
sub
derivatives
synthesis method
coor
cooh
Prior art date
Application number
IL16132002A
Other languages
English (en)
Original Assignee
Bioalliance Pharma
Inst Nat Sante Et Dela Rech Me
Centre Nat Rech Scient
Roussy Inst Gustave
Univ Paris Sud
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioalliance Pharma, Inst Nat Sante Et Dela Rech Me, Centre Nat Rech Scient, Roussy Inst Gustave, Univ Paris Sud filed Critical Bioalliance Pharma
Publication of IL161320A0 publication Critical patent/IL161320A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL16132002A 2001-10-12 2002-10-14 Quinoline derivatives, synthesis method, and medicines containing said derivatives IL161320A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0113209A FR2830863B1 (fr) 2001-10-12 2001-10-12 Derives de quinoleine, procede de synthese, et medicaments renfermant ces derives
PCT/FR2002/003512 WO2003031413A1 (fr) 2001-10-12 2002-10-14 Derives de quinoleine, procede de synthese, et medicaments renfermant ces derives

Publications (1)

Publication Number Publication Date
IL161320A0 true IL161320A0 (en) 2004-09-27

Family

ID=8868255

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16132002A IL161320A0 (en) 2001-10-12 2002-10-14 Quinoline derivatives, synthesis method, and medicines containing said derivatives
IL161320A IL161320A (en) 2001-10-12 2004-04-07 Quinoline derivatives, a method for their synthesis, pharmaceutical compositiions comprising the same and uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL161320A IL161320A (en) 2001-10-12 2004-04-07 Quinoline derivatives, a method for their synthesis, pharmaceutical compositiions comprising the same and uses thereof

Country Status (10)

Country Link
US (2) US7064133B2 (enExample)
EP (1) EP1461319B1 (enExample)
JP (1) JP2005508350A (enExample)
AT (1) ATE430134T1 (enExample)
DE (1) DE60232186D1 (enExample)
DK (1) DK1461319T3 (enExample)
ES (1) ES2326115T3 (enExample)
FR (1) FR2830863B1 (enExample)
IL (2) IL161320A0 (enExample)
WO (1) WO2003031413A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2830863B1 (fr) * 2001-10-12 2004-01-30 Bioalliance Pharma Derives de quinoleine, procede de synthese, et medicaments renfermant ces derives
FR2839646B1 (fr) * 2002-05-17 2008-04-11 Bioalliance Pharma Utilisation de derives de quinoleine a effet anti-integrase et ses applications
US7132432B2 (en) * 2003-06-05 2006-11-07 Bristol-Myers Squibb Company Hydantoin derivatives as inhibitors of tumor necrosis factor-alpha converting enzyme (TACE)
TW200510425A (en) 2003-08-13 2005-03-16 Japan Tobacco Inc Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor
ATE433974T1 (de) 2003-09-19 2009-07-15 Gilead Sciences Inc Azachinolinolphosphonatverbindungen als integraseinhibitoren
JP2008542352A (ja) * 2005-06-01 2008-11-27 ビオアリアンス ファルマ キノリン化合物及び他のhiv感染治療薬を含む相乗作用のコンビネーション

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2761687B1 (fr) * 1997-04-08 2000-09-15 Centre Nat Rech Scient Derives de quinoleines, possedant notamment des proprietes antivirales, leurs preparations et leurs applications biologiques
FR2830863B1 (fr) * 2001-10-12 2004-01-30 Bioalliance Pharma Derives de quinoleine, procede de synthese, et medicaments renfermant ces derives

Also Published As

Publication number Publication date
US20060148849A1 (en) 2006-07-06
FR2830863B1 (fr) 2004-01-30
EP1461319B1 (fr) 2009-04-29
WO2003031413A1 (fr) 2003-04-17
FR2830863A1 (fr) 2003-04-18
JP2005508350A (ja) 2005-03-31
DK1461319T3 (da) 2009-08-03
US7064133B2 (en) 2006-06-20
ATE430134T1 (de) 2009-05-15
US20040259911A1 (en) 2004-12-23
ES2326115T3 (es) 2009-10-01
IL161320A (en) 2009-09-01
DE60232186D1 (de) 2009-06-10
EP1461319A1 (fr) 2004-09-29

Similar Documents

Publication Publication Date Title
DK1104760T3 (da) Sulfamoylheteroarylpyrazolforbindelser som anti-inflammatoriske/analgetiske midler
MX9204746A (es) Nuevos derivados de tiazolilbenzofuranos, procedimientos para la preparacion de los mismos y las composiciones farmaceuticas que los contienen.
DE69925141D1 (de) Chinazolin derivate
ATE272633T1 (de) Aromatische amiden
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
UY26512A1 (es) Inhibidores no peptídicos de la unión celúlar dependiente de vla - 4 útiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias
PT98358A (pt) Processo para a preparacao de novos compostos pirazolopiridinicos
DK1104759T3 (da) Heteroarylphenylpyrazolforbindelser som antiinflammatoriske/analgetiske midler
DE69309435D1 (de) Restenosehemmer nach perkutaner koronarer arterioplastie
DK0583485T3 (da) Ethanolaminderivater med sympathomimetiske og anti-pollakisuria-virkninger
HUP0100184A2 (hu) Szubsztituált 2-(benzil-amino)-2-fenil-acetamid-vegyületek és ezeket tartalmazó gyógyszerkészítmények
IL161320A (en) Quinoline derivatives, a method for their synthesis, pharmaceutical compositiions comprising the same and uses thereof
TNSN97092A1 (ar) مثبطات انزيم بروتيني فلزي وتركيبات صيدلانية تحتوي على تلك المثبتطات واستخدامها الصيدلاني وطرق ومركبات وسيطة مفيدة لتحضير التركيبات المذكورة.
ES2189080T3 (es) Derivados de creatina para el asma.
AU7529487A (en) Carbamate or urea derivatives, their preparation and pharmaceutical compositions comprising them
PT1430047E (pt) Derivados de alquilaminopiridazinona substituida, processo para a sua preparacao e composicoes farmaceuticas que os contem
DE60009517D1 (de) A-500359-derivate
ITMI922742A1 (it) Composti ad attivita' terapeutica utili per il trattamento di malattie connesse ad una carenza di glutatione, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
BR9813241A (pt) Derivados de guanidina substituìdos
EA200000374A2 (ru) Новые соединения 2,3-метаноаминокислоты, способ их получения и содержащие их фармацевтические композиции
EA200200379A3 (ru) Новые соединения пиримидин-4-она, способ их получения и содержащие их фармацевтические композиции
ATE497497T1 (de) 1,2,4-triazolderivat, verfahren zu dessenherstellung, und dieses enthaltende pharmazeutische zusammensetzung
BR0014319A (pt) Derivados de pirimidina, processo para preparação dos derivados e drogas contendo o mesmos como o ingrediente ativo
PL304334A1 (en) Pharmaceutical composition of gastric protective action, including antiulceric one and method of treating diseases of gastrointestinal tract